Zacks Research Analysts Boost Earnings Estimates for PAHC

Phibro Animal Health Co. (NASDAQ:PAHC) – Research analysts at Zacks Research upped their Q3 2025 earnings per share (EPS) estimates for Phibro Animal Health in a research note issued to investors on Wednesday, March 12th. Zacks Research analyst R. Department now expects that the company will earn $0.50 per share for the quarter, up from their prior forecast of $0.48. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.51 EPS, Q2 2026 earnings at $0.56 EPS, Q3 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.60 EPS, FY2026 earnings at $1.96 EPS, Q2 2027 earnings at $0.56 EPS and FY2027 earnings at $2.21 EPS.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.

Several other equities research analysts have also issued reports on the company. Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $21.25 on Friday. The firm has a market cap of $860.69 million, a PE ratio of 44.27, a PEG ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a 12 month low of $12.05 and a 12 month high of $26.55. The stock has a 50 day moving average of $22.57 and a 200 day moving average of $22.57. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Institutional Trading of Phibro Animal Health

A number of institutional investors have recently made changes to their positions in the business. Millennium Management LLC lifted its position in Phibro Animal Health by 233.0% during the 4th quarter. Millennium Management LLC now owns 207,749 shares of the company’s stock worth $4,363,000 after acquiring an additional 145,359 shares during the period. Jacobs Levy Equity Management Inc. increased its stake in shares of Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company’s stock valued at $6,325,000 after purchasing an additional 108,918 shares in the last quarter. Hussman Strategic Advisors Inc. purchased a new stake in Phibro Animal Health during the 4th quarter worth approximately $2,205,000. Nuveen Asset Management LLC increased its stake in Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after buying an additional 103,618 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in shares of Phibro Animal Health by 357.1% during the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after purchasing an additional 101,560 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.26%. Phibro Animal Health’s payout ratio is 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.